Weeks after announcing significant expansion of its production capacity at its Brazilian facility, Californian precision fermentation specialist Amyris has entered into a strategic collaboration with German specialty chemicals company Wacker. This partnership aims to leverage cutting-edge biotechnology to develop and commercialize a new generation of bio-based, sustainable ingredients for the global personal care sector. The alliance signifies a pivotal moment for both companies, merging Wacker’s deep expertise in formulation and application technology with Amyris’s pioneering capabilities in synthetic biology and precision fermentation, promising to accelerate the delivery of innovative and environmentally responsible solutions to the cosmetics and personal care market.
The collaboration, built upon an existing long-standing relationship between the two firms, will see Wacker and Amyris working in closer concert to thoroughly evaluate the potential of bio-based substances and basic chemicals specifically tailored for the personal care industry. Their joint efforts will focus on exploring novel development pathways and advancing them through a structured, systematic process. The ultimate objective is the creation of high-performance, precision-fermented raw materials and functional substances that can be seamlessly integrated into a wide array of cosmetic and personal care formulations.
Lisa Roessler, Head of Sales and Marketing at Amyris, articulated the synergistic potential of this alliance. "By combining Wacker’s profound formulation and application technology expertise with Amyris’s biochemistry competence, a unique partnership is being created that is capable of scaling innovations in renewable biochemistry into highly effective cosmetic active ingredients," Roessler stated. This sentiment was echoed by Ian Moore, a personal care expert at Wacker, who noted, "We are currently investigating whether we can specifically expand and complement our personal care portfolio with certain raw materials from Amyris."
Amyris’s recent capacity expansion in Brazil is a key catalyst for this intensified collaboration. The company has been a significant player in the synthetic biology landscape, operating a vertically integrated biomanufacturing setup designed to produce customized sustainable ingredients. At the core of Amyris’s technological prowess lies precision fermentation. This advanced process involves the precise insertion of specific DNA sequences into microorganisms, effectively instructing them to produce desired molecules such as proteins, fats, vitamins, pigments, and flavor compounds when subjected to fermentation. This capability allows Amyris to transform renewable raw materials into high-performance molecules for diverse industries, including flavors and fragrances, beauty and personal care, and specialty chemicals.
The recent installation of a 2x80m³ configuration at Amyris’s facility in Barra Bonita, Brazil, has significantly boosted its operational capacity. This expansion has resulted in four fully independent operational production lines, enabling the company to accelerate its scale-up efforts and enhance the efficiency of its molecule production. This improved availability and scalable production of biomanufactured products are precisely what make Amyris’s offerings attractive to established chemical giants like Wacker. The strategic focus of the Wacker-Amyris collaboration will be on bio-based molecules whose inherent functional potential can be further unlocked and optimized through Wacker’s specialized processing and formulation techniques.
Wacker, a company with over a century of history, has established itself as a leading developer of highly specialized chemical and biotechnological products. Its existing portfolio includes products derived from the fermentation of cyclodextrins and cysteine, catering to the personal care and life science sectors. The German firm is now actively exploring the extent to which Amyris’s bio-based raw materials can be effectively integrated into Wacker’s established production structures. This integration is crucial for ensuring the seamless transition of novel bio-based ingredients from the laboratory to large-scale commercialization.
"The development of market-ready solutions and the formulation and application compatibility of such products for the customer are significantly influenced by Wacker’s development, formulation, and production expertise," Moore elaborated. To expedite the creation of planet-friendly personal care ingredients, Wacker will contribute its comprehensive formulation and application expertise, while Amyris will provide its deep knowledge in biotechnology and biomanufacturing. This division of labor leverages the core strengths of each organization, creating a powerful synergy.
Roessler further elaborated on Wacker’s role and the benefits of the partnership: "Wacker is a leading developer of functional ingredients for the cosmetics and personal care industries. The company operates technical application and testing centers worldwide and therefore understands customer expectations for such products. Combining these strengths creates synergies and a strong foundation for developing innovative, high-performance, and resource-efficient solutions."
This collaboration is not an isolated event but rather a reflection of a broader and intensifying sustainability shift within the personal care industry. Consumers are increasingly demanding products that are not only effective but also ethically sourced and environmentally benign. This demand has spurred a wave of innovation, with numerous startups leveraging the power of fermentation to create eco-friendly alternatives to conventional ingredients. For instance, companies like Savor, Melt&Marble, Aio, and NoPalm Ingredients are utilizing fermentation to produce sustainable substitutes for palm oil and petroleum-based mineral oils, which are common components in cosmetics and beauty products.
In response to this burgeoning market trend, Wacker recently unveiled its new brand, Belnexrt, at the In-Cosmetics trade show in Paris. This new brand is dedicated to showcasing products formulated exclusively from renewable raw materials, signaling Wacker’s commitment to a more sustainable future for personal care. "This allows us to offer manufacturers and formulators of personal care products a wide range of ingredients, from proven silicon-based solutions to plant-based products that offer similar properties but are completely bio-based," Moore explained, highlighting the company’s strategic pivot towards sustainable offerings.
The implications of this partnership extend beyond product development. It signifies a growing willingness among established chemical companies to embrace and integrate novel biotechnological approaches. The precision fermentation technology employed by Amyris offers a scalable and sustainable method for producing complex molecules that were previously difficult or impossible to synthesize economically through traditional chemical means. This can lead to the development of ingredients with enhanced performance characteristics, unique functionalities, and a significantly reduced environmental footprint compared to their petroleum-derived counterparts.
The collaboration also underscores the critical role of strategic partnerships in driving innovation in the bioeconomy. By combining Wacker’s extensive market reach, regulatory expertise, and formulation know-how with Amyris’s advanced biomanufacturing capabilities, the two companies are well-positioned to bring novel sustainable ingredients to market more rapidly and effectively. This approach can serve as a model for other industry players seeking to navigate the transition towards a more sustainable and circular economy.
Furthermore, the focus on the personal care sector is particularly noteworthy. This industry has historically been a significant consumer of petroleum-based ingredients, but it is also one of the most responsive to consumer demand for natural and sustainable alternatives. The success of initiatives like the Wacker-Amyris partnership could pave the way for the widespread adoption of bio-based ingredients across a broader range of consumer goods, contributing to a substantial reduction in the chemical industry’s reliance on fossil fuels. The timeline for the full realization of these products will depend on the rigorous testing, regulatory approvals, and market adoption processes, but the foundational collaboration is now firmly in place, marking a significant step forward in the quest for truly sustainable personal care solutions.